PDCD1 and primary cutaneous T-cell non-Hodgkin lymphoma: As the SpatialScore appears to predict the outcome of PD-1 blockade in CTCL, it stands to reason that there is a deep phenotype of cell type-specific architecture that is driving this spatial biomarker.